In a significant shift, the US Food and Drug Administration (FDA) has announced its plan to reduce its reliance on animal testing for drug development. This is especially for monoclonal antibody ...

The Food and Drug Administration on Thursday said it would begin phasing out animal testing requirements for antibody therapies and other drugs and move toward AI-based models and other tools it deems ...

(Reuters) -Drug developers are increasing adoption of AI technologies for discovery and safety testing to get faster and cheaper results, in line with an FDA push to reduce animal testing in the near ...

(Reuters) — The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal antibody therapies and other drugs with “human-relevant methods,” ...

The FDA is moving away from requiring animal models for investigational new drug (IND) applications for new monoclonal antibodies and some other drug candidates. Animal testing will be "reduced, ...

Drugs have been tested on animals for over a century, but new technology may one day eliminate the need to do so. Congress and the FDA are pushing pharmaceutical companies to replace animals with ...

(CNN) — The US Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies and other drugs be tested on animals, saying in a news release that ...

The FDA will begin replacing animal testing in the development of monoclonal antibody therapies and other drugs with human-based methods. The agency said the new approach will aim to improve drug ...

The Food and Drug Administration and National Institutes of Health held a joint workshop July 7 on reducing animal testing in research, strikingly announcing that “NIH will no longer seek proposals ...

The U.S. Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies and other drugs be tested on animals, saying in a news release that there ...